Back
Creative Realities Vs. Sarepta Therapeutics Industry Stock Comparison
Sell
43
CREX
Creative Realities
Last Price:
$1.69
Seasonality Move:
-1.22%
Sell
42
SRPT
Sarepta Therapeutics
Last Price:
$36.26
Seasonality Move:
13.8%
Sell
43
Creative Realities (CREX)
is a Sell
Is Creative Realities a Buy, Sell or Hold?
-
The current Creative Realities [CREX] share price is $1.68. The Score for CREX is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
CREX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $36.27. The Score for SRPT is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CREX Stock Price Chart
What is Creative Realities's stock price today?
-
The Creative Realities share price today is $1.68The current trend is moderately bullish and CREX is experiencing selling pressure, which indicates risk of future bearish movement.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $36.27Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.
CREX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.12 | Buy |
Relative Strength Index (14 RSI): | 48.07 | Sell |
Chaikin Money Flow: | -7049 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.39 - 1.81) | Buy |
Bollinger Bands (100): | (1.72 - 2.68) | Sell |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -7.02 | Sell |
Relative Strength Index (14 RSI): | 22.68 | Sell |
Chaikin Money Flow: | -5425494 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (46.24 - 62.32) | Sell |
Bollinger Bands (100): | (65.54 - 121.78) | Sell |
CREX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.77 | Sell |
20-day SMA: | 1.61 | Buy |
50-day SMA: | 1.77 | Sell |
200-day SMA: | 3.21 | Sell |
8-day EMA: | 1.72 | Sell |
20-day EMA: | 1.65 | Buy |
50-day EMA: | 1.29 | Buy |
200-day EMA: | 0.52 | Buy |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 51.08 | Sell |
20-day SMA: | 54.75 | Sell |
50-day SMA: | 69.96 | Sell |
200-day SMA: | 111.27 | Sell |
8-day EMA: | 46.82 | Sell |
20-day EMA: | 54.19 | Sell |
50-day EMA: | 68.41 | Sell |
200-day EMA: | 100.79 | Sell |
Creative Realities Earnings Growth & CREX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.81 per share, an increase next quarter of $0.87 per share, a decrease this year of $3.97 per share, and an increase next year of $8.43 per share.
Creative Realities Technical Analysis
Apr 28 | Apr 29 | Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
28 | 29 | 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Apr 28 | Apr 29 | Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
28 | 29 | 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |